High-Throughput Evaluation of Breast Cancer Markers
No involved investigator sites defined.
The objective of this study is to use a combination of AMT proteomics and ELISA microarray testing to discover and validate novel biomarkers for breast cancer.
There are currently no biomarkers annotated for this protocol.
No datasets are currently associated with this protocol.